Home ยป “Intravitreal Dexamethasone Implant Increases Treatment Intervals in Neovascular Age-Related Macular Degeneration”

“Intravitreal Dexamethasone Implant Increases Treatment Intervals in Neovascular Age-Related Macular Degeneration”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38117666

The study found that adding intravitreal dexamethasone implant to anti-VEGF therapy for neovascular age-related macular degeneration patients with persistent disease activity and high treatment demand resulted in a significant increase in treatment intervals while maintaining stable central retinal thickness and visual acuity, suggesting a potential role of inflammation or steroid-responsive factors in treatment resistance.

You may also like

Leave a Comment